(Total Views: 497)
Posted On: 01/18/2021 3:02:03 PM
Post# of 149003
Re: MD VIROLOGIST #73211
Thanks. I don't expect much variation based on the data shown in Int J Inf Dis paper Figure 2 (D and E), N=10. Is there some other data you are aware of?
Can you shed any light on how accurate is the RO testing, in terms of test-retest reliability on the same sample? or do you know what is the truth about HIV BLA and RO testing by InCellDx: did FDA reject the InCellDx methods (which seems to be what Nader indicated on one of the calls and in an interview), and if so, why? A recent announcement from InCellDX seemed to indicate they were marketing the test, so does that mean FDA now approves of the InCellDx assay as described in the paper?
Can you shed any light on how accurate is the RO testing, in terms of test-retest reliability on the same sample? or do you know what is the truth about HIV BLA and RO testing by InCellDx: did FDA reject the InCellDx methods (which seems to be what Nader indicated on one of the calls and in an interview), and if so, why? A recent announcement from InCellDX seemed to indicate they were marketing the test, so does that mean FDA now approves of the InCellDx assay as described in the paper?
(0)
(0)Scroll down for more posts ▼
